PRESS RELEASE published on 07/30/2025 at 16:00, 11 months 9 days ago ALT5 Sigma Corporation and Fundamental Interaction Usher in New Era of Institutional Crypto Trading Access for Finra Broker-Dealers ALT5 Sigma Corporation integrates ALT5 Prime FIX API with Fundamental Interaction, enabling regulated firms to access digital asset markets seamlessly. The move bridges traditional capital markets with crypto execution for FINRA-registered broker-dealers and ATSs ALT5 Sigma Corporation ALT5 Prime FIX API Fundamental Interaction Cryptocurrency Execution FINRA-registered Broker-dealers
PRESS RELEASE published on 07/30/2025 at 15:25, 11 months 9 days ago Metallic Minerals Closes C$6 Million Brokered Private Placement Financing Metallic Minerals Corp. completed a brokered private placement financing of C$6,000,024 for advancing projects in Colorado and Yukon. Cormark Securities Inc. led the Offering Private Placement Financing Exploration Projects Metallic Minerals Corp. Cormark Securities Inc.
PRESS RELEASE published on 07/30/2025 at 15:15, 11 months 9 days ago ReelTime's RI Unlocks 2.8 Billion-Device Market Allowing Android Users Worldwide Reel Intelligence Without App Store Restrictions with Direct Deployment Skipping Google Play Store ReelTime's Reel Intelligence 'RI' achieves direct installation on 2.8 billion Android devices worldwide, offering next-gen AI capabilities. No app store required, creating a new era in AI access and distribution AI Capabilities Android Devices ReelTime RI Reel Intelligence
PRESS RELEASE published on 07/30/2025 at 15:04, 11 months 9 days ago PSI still on growth track after six months PSI Group reports strong growth in new orders, revenue, and operating results in the first half of 2025, with positive outlook for the full year Revenue Growth Operating Results New Orders PSI Group
PRESS RELEASE published on 07/30/2025 at 15:00, 11 months 9 days ago Xenetic Biosciences, Inc. Announces Entry by Collaboration Partner into Clinical Study Agreement to Advance Development of DNase Platform for the Treatment of Large B Cell Lymphoma Xenetic Biosciences collaborates with PeriNess for an exploratory clinical study of DNase I with anti-CD19 CAR T cells in large B cell lymphoma patients at Tel Aviv Sourasky Medical Center Xenetic Biosciences DNase I PeriNess Large B Cell Lymphoma Anti-CD19 CAR T Cells
PRESS RELEASE published on 07/30/2025 at 15:00, 11 months 9 days ago FRP Holdings, Inc. Announces Release Date for Its 2025 Second Quarter Earnings and Details for the Earnings Conference Call FRP Holdings, Inc. (NASDAQ: FRPH) to release Q2 earnings on August 6, 2025, with a conference call on August 7, 2025. Details for access provided. Company involved in real estate business Financial Results Conference Call Earnings Real Estate Business FRP Holdings Inc.
PRESS RELEASE published on 07/30/2025 at 15:00, 11 months 9 days ago Safe & Green Holdings Restructures Recent Transaction, Reducing Dilution and Complies with NASDAQ Panel Requirements Safe & Green Holdings Corp. restructures private placement with D. Boral Capital, cancelling Series A and Series B Warrants to reduce dilution by 70%. Complies with NASDAQ standards Private Placement Restructuring Nasdaq Compliance Safe & Green Holdings Corp. Cancellation Of Warrants
PRESS RELEASE published on 07/30/2025 at 14:50, 11 months 9 days ago Spetz Inc Begins Trading on the OTCQB Exchange Under the Ticker Symbol DBKSF Spetz Inc. (CSE:SPTZ)(OTCQB:DBKSF) uplisted to OTCQB, enhancing U.S. investors' access to Sonic blockchain ecosystem. Company expands digital asset strategy OTCQB Spetz Inc. U.S. Investors Digital Asset Strategy Sonic Blockchain Ecosystem
PRESS RELEASE published on 07/30/2025 at 14:30, 11 months 9 days ago Measles Cases Increasing Worldwide, Need the New NV-387 Broad-Spectrum Antiviral to Combat, Says NanoViricides NanoViricides introduces drug candidate NV-387 as a potential treatment for Measles outbreak. The drug has shown safety and effectiveness in animal studies and Phase I trial, aiming to combat the global epidemic NanoViricides NV-387 Antiviral Vaccination Measles
PRESS RELEASE published on 07/30/2025 at 14:29, 11 months 9 days ago INSIDE INFORMATION / OTHER NEWS RELEASES Medincell's partner Teva Pharmaceuticals raises 2025 revenue outlook for UZEDY® to $190–$200M and confirms Olanzapine LAI on track for submission in 2025 Revenue Outlook Medincell Teva Pharmaceuticals Olanzapine LAI Submission
Published on 07/09/2026 at 00:00, 5 hours 59 minutes ago Alset AI Announces Closing of Shares for Debt Transaction
Published on 07/08/2026 at 15:25, 14 hours 34 minutes ago Rockhaven Announces Granting of Incentive Stock Options
Published on 07/08/2026 at 15:00, 14 hours 59 minutes ago Karbon-X Announces Strategic Partnership to Evaluate Kenya BioHub Initiative
Published on 07/08/2026 at 15:00, 14 hours 59 minutes ago GameSquare's Stream Hatchet Publishes Esports Live Streaming Trends Report
Published on 07/09/2026 at 01:20, 4 hours 38 minutes ago ZEAL acquires SevenCanyon and enters the highly attractive UK prize draw market
Published on 07/09/2026 at 01:18, 4 hours 40 minutes ago EQS-Adhoc: ZEAL Network SE to acquire SevenCanyon and enter the United Kingdom market
Published on 07/08/2026 at 23:08, 6 hours 50 minutes ago EQS-Adhoc: PSI Software SE: Publication of 2025 annual and consolidated financial statements postponed again by a few days
Published on 07/08/2026 at 21:00, 8 hours 58 minutes ago Legendary Entertainment and Warner Bros. Pictures Unveil Dune: Part Three Trailer and Behind-the-Scenes Images Showcasing Abu Dhabi as Arrakis
Published on 07/08/2026 at 18:00, 11 hours 59 minutes ago €464 MILLION OF NEW FINANCING TO SUPPORT FREY'S GROWTH
Published on 07/08/2026 at 17:45, 12 hours 14 minutes ago Half-year liquidity contract statement of ALTEN SA as at 30 June 2026
Published on 07/08/2026 at 17:40, 12 hours 19 minutes ago Report on share repurchases from 1 to 7 July 2026
Published on 07/08/2026 at 11:15, 18 hours 44 minutes ago Half-year statement of the liquidity contract H1 2026